A New Formulation of Intravenous Paracetamol for Fever Management

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Fever
Interventions
DRUG

APOTEL max

The study drug is provided in a form of bag with 100ml final volume and it is directly connected to the infusion device that leads to a catheter already cannulated in one antecubital vein.

DRUG

Placebo

Placebo is provided in a form of bag with 100ml final volume and it is directly connected to the infusion device that leads to a catheter already cannulated in one antecubital vein. Placebo contains water for injection and inactive vehicles.

Trial Locations (6)

12462

Attikon Hospital, Haidari/Athens

19018

Thriasion Elefsis General Hospital, Magoula Attikis

26504

University Hospital of Patras, Rion/Patras

34100

General Hospital of Chalkida, Chalcis

54642

General Hospital Of Thessaloniki Ippokratio, Thessaloniki

71110

University Hospital of Crete, Heraklion

All Listed Sponsors
collaborator

Attikon Hospital

OTHER

collaborator

University Hospital of Patras

OTHER

collaborator

University Hospital of Crete

OTHER

collaborator

Thriasio General Hospital of Elefsina

OTHER

collaborator

General Hospital Of Thessaloniki Ippokratio

OTHER

collaborator

General Hospital of Chalkida

OTHER_GOV

lead

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.

INDUSTRY

NCT02283203 - A New Formulation of Intravenous Paracetamol for Fever Management | Biotech Hunter | Biotech Hunter